Evidence map›Paper›PMID 35860346›Full record

ArticleCancer informatics2022

Complex Disease Individual Molecular Characterization Using Infinite Sparse Graphical Independent Component Analysis.

Sarah-Laure Rincourt, Stefan Michiels, Damien Drubay

Open access · goldAbstract read
In one paragraph

Article in Cancer informatics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Sarah-Laure RincourtOncostat U1018, Inserm, University Paris-Saclay, Labelled Ligue Contre le Cancer, Villejuif, France.ORCID https://orcid.org/0000-0003-0367-3254
Stefan MichielsOncostat U1018, Inserm, University Paris-Saclay, Labelled Ligue Contre le Cancer, Villejuif, France.
Damien DrubayOncostat U1018, Inserm, University Paris-Saclay, Labelled Ligue Contre le Cancer, Villejuif, France.
Inserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Identifying individual mechanisms involved in complex diseases, such as cancer, is essential for precision medicine. Their characterization is particularly challenging due to the unknown relationships of high-dimensional omics data and their inter-patient heterogeneity. We propose to model individual gene expression as a combination of unobserved molecular mechanisms (molecular components) that may differ between the individuals. Considering a baseline molecular profile common to all individuals, these molecular components may represent molecular pathways differing from the population background. We defined an infinite sparse graphical independent component analysis (isgICA) to identify these molecular components. This model relies on double sparseness: the source matrix sparseness defines the subset of genes involved in each molecular component, whereas the weight matrix sparseness identifies the subset of molecular components associated with each patient. As the number of molecular components is unknown but likely high, we simultaneously inferred it and the weight matrix sparseness using the beta-Bernoulli process (BBP). We simulated data from a double sparse ICA with 10/30 components with specific sparseness structures for 100/500 individuals and 500/1000/5000 genes with different noise variance levels to evaluate the reconstruction of the latent structures by our model. For all simulations, the isgICA was able to reconstruct with higher accuracy than 2 state-of-the-art methods (

Indexed as

gene expressionindependent component analysisindividual heterogeneitymolecular mechanismsNonparametric Bayesian model

Identifiers

PMID35860346
PMCPMC9290103
OpenAlexW4285612736

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.